Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: Report of a case

Diseases of the Colon and Rectum

Volumn 48, Issue 11, 2005, Pages 2144-2147

  Shitrit, David ^a   Shitrit, Ariella Bar Gil ^b   Dickman, Ram ^a   Sahar, Gidon ^a   Saute, Milton ^a   Kramer, Mordechai R ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Colon; Lung transplantation; Lymphoma

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; AGED; ANAMNESIS; ARTICLE; BLOODY DIARRHEA; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; COLON DISEASE; COLONOSCOPY; DRUG DOSE REDUCTION; EPSTEIN BARR VIRUS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NAUSEA; RECIPIENT; SEROLOGY; SMALL INTESTINE DISEASE; STOMACH DISEASE; TREATMENT FAILURE; TREATMENT RESPONSE;

AGED; COLONIC NEOPLASMS; HUMANS; LUNG TRANSPLANTATION; LYMPHOMA, B-CELL; MALE; PULMONARY FIBROSIS;

EID: 29844443614     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-005-0116-7     Document Type: Article

References (16)

1. S Paranjothi RD Yusen MD Kraus JP Lynch GA Patterson EP Trulock 2001 Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases J Heart Lung Transplant 20 1054 63
2. SM Levine L Angel A Anzueto 1999 A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients Chest 116 1273 7
3. JM Armitage RL Kormos RS Stuart 1991 Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression J Heart Lung Transplant 10 877 86
4. RM Aris DM Maia IP Neuringer 1996 Posttransplant lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient Am J Respir Crit Care Med 154 1712 7
5. RC Walker CV Paya WF Marshall 1995 Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantation J Heart Lung Transplant 14 214 21
6. LF Angel TH Cai EY Sako SM Levine 2000 Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center Ann Transplant 5 26 30
7. P Ramalingam L Rybicki D Smith 2002 Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience Mol Pathol 15 647 56
8. BL Wood D Sabath VC Broudy G Raghu 1996 The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients Cancer 78 2223 8
9. ISHLT. 16th annual data report. Available at: http://www.ishlt.org/ registry.html. Accessed June 15, 2000
10. I Penn 1990 Cancer complicated organ transplantation N Engl J Med 323 1767 9
11. MA Nalesnik L Makowka TE Starzl 1988 The diagnosis and treatment of posttransplant lymphoproliferative disorders Curr Probl Surg 25 367 472
12. K Cox L Lawrence-Miyasaki R Garcia-Kennedy 1995 An increased incidence of EBV and lymphoproliferative disorder in young children on FK 506 after liver transplantation Transplantation 559 524 9
13. I Penn 1991 The changing pattern of posttransplant malignancies Transplant Proc 23 1101 3
14. LJ Swinnen M Costanzo S Fisher 1990 Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients N Engl J Med 323 1723 8
15. EA Verschuuren SJ Stevens GW van Imhoff 2002 Treatment of posttransplant lymphoproliferative disease: the remission, the relapse, and the complication Transplantation 15 110 4
16. RC Cook JM Connors RD Gascoyne G Frodet RD Levy 2000 Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation Lancet 354 1698 9